Mental Health Medications - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

TABLE OF CONTENTS

1 Market Overview

• 1.1 Mental Health Medications Product Introduction
• 1.2 Global Mental Health Medications Market Size Forecast
  • 1.2.1 Global Mental Health Medications Sales Value (2020-2031)
  • 1.2.2 Global Mental Health Medications Sales Volume (2020-2031)
  • 1.2.3 Global Mental Health Medications Sales Price (2020-2031)
• 1.3 Mental Health Medications Market Trends & Drivers
  • 1.3.1 Mental Health Medications Industry Trends
  • 1.3.2 Mental Health Medications Market Drivers & Opportunity
  • 1.3.3 Mental Health Medications Market Challenges
  • 1.3.4 Mental Health Medications Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Mental Health Medications Players Revenue Ranking (2024)
• 2.2 Global Mental Health Medications Revenue by Company (2020-2025)
• 2.3 Global Mental Health Medications Players Sales Volume Ranking (2024)
• 2.4 Global Mental Health Medications Sales Volume by Company Players (2020-2025)
• 2.5 Global Mental Health Medications Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Mental Health Medications Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Mental Health Medications Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Mental Health Medications
• 2.9 Mental Health Medications Market Competitive Analysis
  • 2.9.1 Mental Health Medications Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Mental Health Medications Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Health Medications as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Antidepressants
  • 3.1.2 Antipsychotics
  • 3.1.3 Antianxiety Medications
  • 3.1.4 Others
• 3.2 Global Mental Health Medications Sales Value by Type
  • 3.2.1 Global Mental Health Medications Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Mental Health Medications Sales Value, by Type (2020-2031)
  • 3.2.3 Global Mental Health Medications Sales Value, by Type (%) (2020-2031)
• 3.3 Global Mental Health Medications Sales Volume by Type
  • 3.3.1 Global Mental Health Medications Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Mental Health Medications Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Mental Health Medications Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Mental Health Medications Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Pharmacy
  • 4.1.3 Clinic
  • 4.1.4 Others
• 4.2 Global Mental Health Medications Sales Value by Application
  • 4.2.1 Global Mental Health Medications Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Mental Health Medications Sales Value, by Application (2020-2031)
  • 4.2.3 Global Mental Health Medications Sales Value, by Application (%) (2020-2031)
• 4.3 Global Mental Health Medications Sales Volume by Application
  • 4.3.1 Global Mental Health Medications Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Mental Health Medications Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Mental Health Medications Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Mental Health Medications Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Mental Health Medications Sales Value by Region
  • 5.1.1 Global Mental Health Medications Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Mental Health Medications Sales Value by Region (2020-2025)
  • 5.1.3 Global Mental Health Medications Sales Value by Region (2026-2031)
  • 5.1.4 Global Mental Health Medications Sales Value by Region (%), (2020-2031)
• 5.2 Global Mental Health Medications Sales Volume by Region
  • 5.2.1 Global Mental Health Medications Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Mental Health Medications Sales Volume by Region (2020-2025)
  • 5.2.3 Global Mental Health Medications Sales Volume by Region (2026-2031)
  • 5.2.4 Global Mental Health Medications Sales Volume by Region (%), (2020-2031)
• 5.3 Global Mental Health Medications Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Mental Health Medications Sales Value, 2020-2031
  • 5.4.2 North America Mental Health Medications Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Mental Health Medications Sales Value, 2020-2031
  • 5.5.2 Europe Mental Health Medications Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Mental Health Medications Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Mental Health Medications Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Mental Health Medications Sales Value, 2020-2031
  • 5.7.2 South America Mental Health Medications Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Mental Health Medications Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Mental Health Medications Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Mental Health Medications Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Mental Health Medications Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Mental Health Medications Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Mental Health Medications Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Mental Health Medications Sales Value, 2020-2031
  • 6.3.2 United States Mental Health Medications Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Mental Health Medications Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Mental Health Medications Sales Value, 2020-2031
  • 6.4.2 Europe Mental Health Medications Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Mental Health Medications Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Mental Health Medications Sales Value, 2020-2031
  • 6.5.2 China Mental Health Medications Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Mental Health Medications Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Mental Health Medications Sales Value, 2020-2031
  • 6.6.2 Japan Mental Health Medications Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Mental Health Medications Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Mental Health Medications Sales Value, 2020-2031
  • 6.7.2 South Korea Mental Health Medications Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Mental Health Medications Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Mental Health Medications Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Mental Health Medications Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Mental Health Medications Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Mental Health Medications Sales Value, 2020-2031
  • 6.9.2 India Mental Health Medications Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Mental Health Medications Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Pfizer
  • 7.1.1 Pfizer Company Information
  • 7.1.2 Pfizer Introduction and Business Overview
  • 7.1.3 Pfizer Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Pfizer Mental Health Medications Product Offerings
  • 7.1.5 Pfizer Recent Development
• 7.2 Teva
  • 7.2.1 Teva Company Information
  • 7.2.2 Teva Introduction and Business Overview
  • 7.2.3 Teva Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Teva Mental Health Medications Product Offerings
  • 7.2.5 Teva Recent Development
• 7.3 Bayer
  • 7.3.1 Bayer Company Information
  • 7.3.2 Bayer Introduction and Business Overview
  • 7.3.3 Bayer Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Bayer Mental Health Medications Product Offerings
  • 7.3.5 Bayer Recent Development
• 7.4 Eli Lilly
  • 7.4.1 Eli Lilly Company Information
  • 7.4.2 Eli Lilly Introduction and Business Overview
  • 7.4.3 Eli Lilly Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Eli Lilly Mental Health Medications Product Offerings
  • 7.4.5 Eli Lilly Recent Development
• 7.5 GlaxoSmithKline
  • 7.5.1 GlaxoSmithKline Company Information
  • 7.5.2 GlaxoSmithKline Introduction and Business Overview
  • 7.5.3 GlaxoSmithKline Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 GlaxoSmithKline Mental Health Medications Product Offerings
  • 7.5.5 GlaxoSmithKline Recent Development
• 7.6 AbbVie
  • 7.6.1 AbbVie Company Information
  • 7.6.2 AbbVie Introduction and Business Overview
  • 7.6.3 AbbVie Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 AbbVie Mental Health Medications Product Offerings
  • 7.6.5 AbbVie Recent Development
• 7.7 Otsuka Pharmaceutical
  • 7.7.1 Otsuka Pharmaceutical Company Information
  • 7.7.2 Otsuka Pharmaceutical Introduction and Business Overview
  • 7.7.3 Otsuka Pharmaceutical Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Otsuka Pharmaceutical Mental Health Medications Product Offerings
  • 7.7.5 Otsuka Pharmaceutical Recent Development
• 7.8 Novartis
  • 7.8.1 Novartis Company Information
  • 7.8.2 Novartis Introduction and Business Overview
  • 7.8.3 Novartis Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Novartis Mental Health Medications Product Offerings
  • 7.8.5 Novartis Recent Development
• 7.9 Allergan
  • 7.9.1 Allergan Company Information
  • 7.9.2 Allergan Introduction and Business Overview
  • 7.9.3 Allergan Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Allergan Mental Health Medications Product Offerings
  • 7.9.5 Allergan Recent Development
• 7.10 Johnson & Johnson
  • 7.10.1 Johnson & Johnson Company Information
  • 7.10.2 Johnson & Johnson Introduction and Business Overview
  • 7.10.3 Johnson & Johnson Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Johnson & Johnson Mental Health Medications Product Offerings
  • 7.10.5 Johnson & Johnson Recent Development
• 7.11 Oakwood Labs
  • 7.11.1 Oakwood Labs Company Information
  • 7.11.2 Oakwood Labs Introduction and Business Overview
  • 7.11.3 Oakwood Labs Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Oakwood Labs Mental Health Medications Product Offerings
  • 7.11.5 Oakwood Labs Recent Development
• 7.12 Sumitomo Dainippon Pharma
  • 7.12.1 Sumitomo Dainippon Pharma Company Information
  • 7.12.2 Sumitomo Dainippon Pharma Introduction and Business Overview
  • 7.12.3 Sumitomo Dainippon Pharma Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Sumitomo Dainippon Pharma Mental Health Medications Product Offerings
  • 7.12.5 Sumitomo Dainippon Pharma Recent Development
• 7.13 Mylan
  • 7.13.1 Mylan Company Information
  • 7.13.2 Mylan Introduction and Business Overview
  • 7.13.3 Mylan Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Mylan Mental Health Medications Product Offerings
  • 7.13.5 Mylan Recent Development
• 7.14 MedinCell
  • 7.14.1 MedinCell Company Information
  • 7.14.2 MedinCell Introduction and Business Overview
  • 7.14.3 MedinCell Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 MedinCell Mental Health Medications Product Offerings
  • 7.14.5 MedinCell Recent Development
• 7.15 Bristol Myers Squibb
  • 7.15.1 Bristol Myers Squibb Company Information
  • 7.15.2 Bristol Myers Squibb Introduction and Business Overview
  • 7.15.3 Bristol Myers Squibb Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Bristol Myers Squibb Mental Health Medications Product Offerings
  • 7.15.5 Bristol Myers Squibb Recent Development
• 7.16 Claire Ellen
  • 7.16.1 Claire Ellen Company Information
  • 7.16.2 Claire Ellen Introduction and Business Overview
  • 7.16.3 Claire Ellen Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Claire Ellen Mental Health Medications Product Offerings
  • 7.16.5 Claire Ellen Recent Development
• 7.17 Sanofi S.A
  • 7.17.1 Sanofi S.A Company Information
  • 7.17.2 Sanofi S.A Introduction and Business Overview
  • 7.17.3 Sanofi S.A Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Sanofi S.A Mental Health Medications Product Offerings
  • 7.17.5 Sanofi S.A Recent Development
• 7.18 Janssen
  • 7.18.1 Janssen Company Information
  • 7.18.2 Janssen Introduction and Business Overview
  • 7.18.3 Janssen Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 Janssen Mental Health Medications Product Offerings
  • 7.18.5 Janssen Recent Development
• 7.19 Lundbeck
  • 7.19.1 Lundbeck Company Information
  • 7.19.2 Lundbeck Introduction and Business Overview
  • 7.19.3 Lundbeck Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 Lundbeck Mental Health Medications Product Offerings
  • 7.19.5 Lundbeck Recent Development
• 7.20 Par Pharmaceutical
  • 7.20.1 Par Pharmaceutical Company Information
  • 7.20.2 Par Pharmaceutical Introduction and Business Overview
  • 7.20.3 Par Pharmaceutical Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 Par Pharmaceutical Mental Health Medications Product Offerings
  • 7.20.5 Par Pharmaceutical Recent Development
• 7.21 Meda AB
  • 7.21.1 Meda AB Company Information
  • 7.21.2 Meda AB Introduction and Business Overview
  • 7.21.3 Meda AB Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.21.4 Meda AB Mental Health Medications Product Offerings
  • 7.21.5 Meda AB Recent Development
• 7.22 Alkermes
  • 7.22.1 Alkermes Company Information
  • 7.22.2 Alkermes Introduction and Business Overview
  • 7.22.3 Alkermes Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.22.4 Alkermes Mental Health Medications Product Offerings
  • 7.22.5 Alkermes Recent Development
• 7.23 AstraZeneca
  • 7.23.1 AstraZeneca Company Information
  • 7.23.2 AstraZeneca Introduction and Business Overview
  • 7.23.3 AstraZeneca Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.23.4 AstraZeneca Mental Health Medications Product Offerings
  • 7.23.5 AstraZeneca Recent Development
• 7.24 Sanis Health
  • 7.24.1 Sanis Health Company Information
  • 7.24.2 Sanis Health Introduction and Business Overview
  • 7.24.3 Sanis Health Mental Health Medications Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.24.4 Sanis Health Mental Health Medications Product Offerings
  • 7.24.5 Sanis Health Recent Development

8 Industry Chain Analysis

• 8.1 Mental Health Medications Industrial Chain
• 8.2 Mental Health Medications Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Mental Health Medications Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Mental Health Medications Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer

List of Tables

Table 1. Mental Health Medications Market Trends

Table 2. Mental Health Medications Market Drivers & Opportunity

Table 3. Mental Health Medications Market Challenges

Table 4. Mental Health Medications Market Restraints

Table 5. Global Mental Health Medications Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Mental Health Medications Revenue Market Share by Company (2020-2025)

Table 7. Global Mental Health Medications Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Mental Health Medications Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Mental Health Medications Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Mental Health Medications Manufacturing Base and Headquarters

Table 11. Key Manufacturers Mental Health Medications Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Mental Health Medications

Table 13. Global Mental Health Medications Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Health Medications as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Mental Health Medications Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Mental Health Medications Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Mental Health Medications Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Mental Health Medications Sales Market Share in Value by Type (2020-2025)

Table 20. Global Mental Health Medications Sales Market Share in Value by Type (2026-2031)

Table 21. Global Mental Health Medications Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Mental Health Medications Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Mental Health Medications Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Mental Health Medications Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Mental Health Medications Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Mental Health Medications Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Mental Health Medications Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Mental Health Medications Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Mental Health Medications Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Mental Health Medications Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Mental Health Medications Sales Market Share in Value by Application (2020-2025)

Table 32. Global Mental Health Medications Sales Market Share in Value by Application (2026-2031)

Table 33. Global Mental Health Medications Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Mental Health Medications Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Mental Health Medications Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Mental Health Medications Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Mental Health Medications Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Mental Health Medications Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Mental Health Medications Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Mental Health Medications Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Mental Health Medications Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Mental Health Medications Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Mental Health Medications Sales Value by Region (2020-2025) & (%)

Table 44. Global Mental Health Medications Sales Value by Region (2026-2031) & (%)

Table 45. Global Mental Health Medications Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Mental Health Medications Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Mental Health Medications Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Mental Health Medications Sales Volume by Region (2020-2025) & (%)

Table 49. Global Mental Health Medications Sales Volume by Region (2026-2031) & (%)

Table 50. Global Mental Health Medications Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Mental Health Medications Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Mental Health Medications Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Mental Health Medications Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Mental Health Medications Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Mental Health Medications Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Mental Health Medications Sales Volume, (2026-2031) & (K Units)

Table 57. Pfizer Company Information

Table 58. Pfizer Introduction and Business Overview

Table 59. Pfizer Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. Pfizer Mental Health Medications Product Offerings

Table 61. Pfizer Recent Development

Table 62. Teva Company Information

Table 63. Teva Introduction and Business Overview

Table 64. Teva Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Teva Mental Health Medications Product Offerings

Table 66. Teva Recent Development

Table 67. Bayer Company Information

Table 68. Bayer Introduction and Business Overview

Table 69. Bayer Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Bayer Mental Health Medications Product Offerings

Table 71. Bayer Recent Development

Table 72. Eli Lilly Company Information

Table 73. Eli Lilly Introduction and Business Overview

Table 74. Eli Lilly Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Eli Lilly Mental Health Medications Product Offerings

Table 76. Eli Lilly Recent Development

Table 77. GlaxoSmithKline Company Information

Table 78. GlaxoSmithKline Introduction and Business Overview

Table 79. GlaxoSmithKline Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. GlaxoSmithKline Mental Health Medications Product Offerings

Table 81. GlaxoSmithKline Recent Development

Table 82. AbbVie Company Information

Table 83. AbbVie Introduction and Business Overview

Table 84. AbbVie Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. AbbVie Mental Health Medications Product Offerings

Table 86. AbbVie Recent Development

Table 87. Otsuka Pharmaceutical Company Information

Table 88. Otsuka Pharmaceutical Introduction and Business Overview

Table 89. Otsuka Pharmaceutical Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Otsuka Pharmaceutical Mental Health Medications Product Offerings

Table 91. Otsuka Pharmaceutical Recent Development

Table 92. Novartis Company Information

Table 93. Novartis Introduction and Business Overview

Table 94. Novartis Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Novartis Mental Health Medications Product Offerings

Table 96. Novartis Recent Development

Table 97. Allergan Company Information

Table 98. Allergan Introduction and Business Overview

Table 99. Allergan Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Allergan Mental Health Medications Product Offerings

Table 101. Allergan Recent Development

Table 102. Johnson & Johnson Company Information

Table 103. Johnson & Johnson Introduction and Business Overview

Table 104. Johnson & Johnson Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Johnson & Johnson Mental Health Medications Product Offerings

Table 106. Johnson & Johnson Recent Development

Table 107. Oakwood Labs Company Information

Table 108. Oakwood Labs Introduction and Business Overview

Table 109. Oakwood Labs Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Oakwood Labs Mental Health Medications Product Offerings

Table 111. Oakwood Labs Recent Development

Table 112. Sumitomo Dainippon Pharma Company Information

Table 113. Sumitomo Dainippon Pharma Introduction and Business Overview

Table 114. Sumitomo Dainippon Pharma Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. Sumitomo Dainippon Pharma Mental Health Medications Product Offerings

Table 116. Sumitomo Dainippon Pharma Recent Development

Table 117. Mylan Company Information

Table 118. Mylan Introduction and Business Overview

Table 119. Mylan Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. Mylan Mental Health Medications Product Offerings

Table 121. Mylan Recent Development

Table 122. MedinCell Company Information

Table 123. MedinCell Introduction and Business Overview

Table 124. MedinCell Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. MedinCell Mental Health Medications Product Offerings

Table 126. MedinCell Recent Development

Table 127. Bristol Myers Squibb Company Information

Table 128. Bristol Myers Squibb Introduction and Business Overview

Table 129. Bristol Myers Squibb Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 130. Bristol Myers Squibb Mental Health Medications Product Offerings

Table 131. Bristol Myers Squibb Recent Development

Table 132. Claire Ellen Company Information

Table 133. Claire Ellen Introduction and Business Overview

Table 134. Claire Ellen Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 135. Claire Ellen Mental Health Medications Product Offerings

Table 136. Claire Ellen Recent Development

Table 137. Sanofi S.A Company Information

Table 138. Sanofi S.A Introduction and Business Overview

Table 139. Sanofi S.A Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 140. Sanofi S.A Mental Health Medications Product Offerings

Table 141. Sanofi S.A Recent Development

Table 142. Janssen Company Information

Table 143. Janssen Introduction and Business Overview

Table 144. Janssen Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 145. Janssen Mental Health Medications Product Offerings

Table 146. Janssen Recent Development

Table 147. Lundbeck Company Information

Table 148. Lundbeck Introduction and Business Overview

Table 149. Lundbeck Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 150. Lundbeck Mental Health Medications Product Offerings

Table 151. Lundbeck Recent Development

Table 152. Par Pharmaceutical Company Information

Table 153. Par Pharmaceutical Introduction and Business Overview

Table 154. Par Pharmaceutical Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 155. Par Pharmaceutical Mental Health Medications Product Offerings

Table 156. Par Pharmaceutical Recent Development

Table 157. Meda AB Company Information

Table 158. Meda AB Introduction and Business Overview

Table 159. Meda AB Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 160. Meda AB Mental Health Medications Product Offerings

Table 161. Meda AB Recent Development

Table 162. Alkermes Company Information

Table 163. Alkermes Introduction and Business Overview

Table 164. Alkermes Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 165. Alkermes Mental Health Medications Product Offerings

Table 166. Alkermes Recent Development

Table 167. AstraZeneca Company Information

Table 168. AstraZeneca Introduction and Business Overview

Table 169. AstraZeneca Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 170. AstraZeneca Mental Health Medications Product Offerings

Table 171. AstraZeneca Recent Development

Table 172. Sanis Health Company Information

Table 173. Sanis Health Introduction and Business Overview

Table 174. Sanis Health Mental Health Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 175. Sanis Health Mental Health Medications Product Offerings

Table 176. Sanis Health Recent Development

Table 177. Key Raw Materials Lists

Table 178. Raw Materials Key Suppliers Lists

Table 179. Mental Health Medications Downstream Customers

Table 180. Mental Health Medications Distributors List

Table 181. Research Programs/Design for This Report

Table 182. Key Data Information from Secondary Sources

Table 183. Key Data Information from Primary Sources

List of Figures

Figure 1. Mental Health Medications Product Picture

Figure 2. Global Mental Health Medications Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Mental Health Medications Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Mental Health Medications Sales Volume (2020-2031) & (K Units)

Figure 5. Global Mental Health Medications Sales Price (2020-2031) & (US$/Unit)

Figure 6. Mental Health Medications Report Years Considered

Figure 7. Global Mental Health Medications Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Mental Health Medications Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mental Health Medications Revenue in 2024

Figure 10. Mental Health Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Antidepressants Picture

Figure 12. Antipsychotics Picture

Figure 13. Antianxiety Medications Picture

Figure 14. Others Picture

Figure 15. Global Mental Health Medications Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Mental Health Medications Sales Value Market Share by Type, 2024 & 2031

Figure 17. Global Mental Health Medications Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 18. Global Mental Health Medications Sales Volume Market Share by Type, 2024 & 2031

Figure 19. Global Mental Health Medications Price by Type (2020-2031) & (US$/Unit)

Figure 20. Product Picture of Hospital

Figure 21. Product Picture of Pharmacy

Figure 22. Product Picture of Clinic

Figure 23. Product Picture of Others

Figure 24. Global Mental Health Medications Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 25. Global Mental Health Medications Sales Value Market Share by Application, 2024 & 2031

Figure 26. Global Mental Health Medications Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 27. Global Mental Health Medications Sales Volume Market Share by Application, 2024 & 2031

Figure 28. Global Mental Health Medications Price by Application (2020-2031) & (US$/Unit)

Figure 29. North America Mental Health Medications Sales Value (2020-2031) & (US$ Million)

Figure 30. North America Mental Health Medications Sales Value by Country (%), 2024 VS 2031

Figure 31. Europe Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe Mental Health Medications Sales Value by Country (%), 2024 VS 2031

Figure 33. Asia Pacific Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Mental Health Medications Sales Value by Region (%), 2024 VS 2031

Figure 35. South America Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 36. South America Mental Health Medications Sales Value by Country (%), 2024 VS 2031

Figure 37. Middle East & Africa Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 38. Middle East & Africa Mental Health Medications Sales Value by Country (%), 2024 VS 2031

Figure 39. Key Countries/Regions Mental Health Medications Sales Value (%), (2020-2031)

Figure 40. Key Countries/Regions Mental Health Medications Sales Volume (%), (2020-2031)

Figure 41. United States Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 42. United States Mental Health Medications Sales Value by Type (%), 2024 VS 2031

Figure 43. United States Mental Health Medications Sales Value by Application (%), 2024 VS 2031

Figure 44. Europe Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 45. Europe Mental Health Medications Sales Value by Type (%), 2024 VS 2031

Figure 46. Europe Mental Health Medications Sales Value by Application (%), 2024 VS 2031

Figure 47. China Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 48. China Mental Health Medications Sales Value by Type (%), 2024 VS 2031

Figure 49. China Mental Health Medications Sales Value by Application (%), 2024 VS 2031

Figure 50. Japan Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 51. Japan Mental Health Medications Sales Value by Type (%), 2024 VS 2031

Figure 52. Japan Mental Health Medications Sales Value by Application (%), 2024 VS 2031

Figure 53. South Korea Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 54. South Korea Mental Health Medications Sales Value by Type (%), 2024 VS 2031

Figure 55. South Korea Mental Health Medications Sales Value by Application (%), 2024 VS 2031

Figure 56. Southeast Asia Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 57. Southeast Asia Mental Health Medications Sales Value by Type (%), 2024 VS 2031

Figure 58. Southeast Asia Mental Health Medications Sales Value by Application (%), 2024 VS 2031

Figure 59. India Mental Health Medications Sales Value, (2020-2031) & (US$ Million)

Figure 60. India Mental Health Medications Sales Value by Type (%), 2024 VS 2031

Figure 61. India Mental Health Medications Sales Value by Application (%), 2024 VS 2031

Figure 62. Mental Health Medications Industrial Chain

Figure 63. Mental Health Medications Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed